Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Francisco Batel Marques

A comparison between two recommendations to conduct and report systematic reviews on drug's safety

scientific article published on 16 October 2019

A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.

scientific article

A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment.

scientific article published on 5 February 2016

A systematic review of observational studies evaluating costs of adverse drug reactions

scientific article

A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs

scientific article published on 27 February 2019

An analysis of the effectiveness outcomes of economic studies evaluating ophthalmic drugs: a systematic review

scientific article published on 30 January 2020

Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis

scientific article

Drug-induced hypersensitivity: A 5-year retrospective study in a hospital electronic health records database

scientific article published on 01 August 2018

Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review

scientific article published on 17 September 2019

Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital

scientific article published on 22 May 2019

Methodologic Assessment of the Systematic Reviews of Ophthalmic Adverse Drug Reactions Published in Ophthalmology Journals: A Systematic Review

scientific article published on 05 July 2018

Monitoring antibiotic consumption in the surgery and orthopaedics

scientific article published on 01 January 2006

Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone

scientific article published on 16 September 2015

Number needed to treat (NNT) in clinical literature: an appraisal.

scientific article

Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports.

scientific article

Outcomes From the First 6 Years of Operation of the Central Portugal Pharmacovigilance Unit.

scientific article published on 16 December 2016

Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit

scientific article published in March 2015

Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis

scientific article published on 17 May 2019

Recommendations to conduct and report systematic reviews in medical literature: a scoping review

scientific article published on 11 December 2019

Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients

scientific article published on 27 October 2020

Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis.

scientific article

Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis

scientific article published on 27 September 2019

Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety data.

scientific article

Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events.

scientific article published on 21 April 2013

Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.

scientific article published on 17 March 2014

Statins and risk of cataracts: A systematic review and meta-analysis of observational studies

scientific article published on 01 December 2018

Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons

scientific article published on 28 July 2016

The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer--a systematic review

scientific article

Paulina is supported by:

About Paulina

Help